Nayara G. Tessarollo
Rio De Janeiro, RJ, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Development and validation of a miRNA-based prognostic model for high-grade serous ovarian cancer: a retrospective cohort study.
Journal: Lancet regional health. Americas
Published: October 14, 2025
Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.
Journal: Frontiers in pharmacology
Published: January 24, 2025
Use of patient-derived organotypic tumor spheroids for testing of viral vector gene therapy in combination with checkpoint blockade.
Journal: Molecular therapy. Oncology
Published: October 23, 2024
Single-cell resolution characterization of myeloid-derived cell states with implication in cancer outcome.
Journal: Nature communications
Published: July 31, 2023
Stable expression of shRNA for the control of recombinant adenovirus replication.
Journal: Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica
Published: March 21, 2023
Perspectives for Combining Viral Oncolysis With Additional Immunotherapies for the Treatment of Melanoma.
Journal: Frontiers in molecular biosciences
Published: September 15, 2021
Clinical Applications and Immunological Aspects of Electroporation-Based Therapies.
Journal: Vaccines
Published: April 29, 2021
Nonreplicating Adenoviral Vectors: Improving Tropism and Delivery of Cancer Gene Therapy.
Journal: Cancers
Published: February 26, 2021
Inhibition of CXCR2 plays a pivotal role in re-sensitizing ovarian cancer to cisplatin treatment.
Journal: Aging
Published: September 23, 2020
Chemosensitizing effects of metformin on cisplatin- and paclitaxel-resistant ovarian cancer cell lines.
Journal: Pharmacological reports : PR
Published: June 17, 2017
Last Updated: 09/26/2026